Dilcardia 30mg Tablet 30s
MRP: ₹23.80
Packaging
10 x 1 TAB
Composition
Diltiazem 30mg
Company
J.B. Chemicals
MRP: ₹23.80
Packaging
10 x 1 TAB
Composition
Diltiazem 30mg
Company
J.B. Chemicals
| Medicine | Company | Price | You Save |
|---|---|---|---|
| Dilcal-30mg Tab 10s | Sanofi Aventis | ₹14.75 | Save ₹9.05 |
| Angizem 30mg Tablet 10s | Sun Pharma | ₹24.37 | — |
| Channel 30mg Tablet 10s | Micro Labs | ₹24.42 | — |
| Dilgard 30 mg Tablet 10s | Cipla | ₹27.50 | — |
| Dilzem 30mg Tablet 10s | Torrent Pharma | ₹36.57 | — |
Diltiazem is used in the treatment of high blood pressure and angina pectoris (chest pain). Diltiazem comes under the class of calcium channel blocker and reduces blood pressure relaxing the blood vessels.
Headache, ankle oedema, hypotension, dizziness, fatigue, flushing, nausea, GI discomfort, gingival hyperplasia, rashes, erythema multiforme, exfoliative dermatitis, photosensitivity, occasionally hepatitis. Potentially Fatal: AV block, bradycardia, asystole, sinus arrest.
Increases serum theophylline levels. Cimetidine may increase plasma concentrations of diltiazem. Concurrent use may lead to increased blood ciclosporin levels. Potentially Fatal: Increased depression of cardiac conduction with amiodarone, β-blockers, digoxin and mefloquine. May potentiate risk of bradycardia and conduction disturbance of propranolol and risk of neurotoxicity of lithium.
Sick-sinus syndrome; 2nd or 3rd ° AV block; porphyria. Severe congestive cardiac failure; marked bradycardia. Pregnancy and lactation.
Diltiazem relaxes coronary vascular smooth muscles by inhibiting influx of calcium ions during depolarisation of the vascular smooth muscles and myocardium. It increases myocardial O2 delivery in patients with vasospastic angina and inhibits cardiac conduction, particularly at the SA and AV nodes. Absorption: Rapidly and almost completely absorbed from the GI tract (oral). Distribution: Enters breast milk. Protein-binding: 80%. Metabolism: Hepatic: Extensive first-pass effect; yields desacetyldiltiazem (posseses 25-50% of the activity of the parent drug). Excretion: Via urine (2-4% as unchanged and metabolites), via bile (remaining metabolites); 3-5 hr (elimination half-life).
Elderly. Hepatic or renal impairment; impaired left ventricular function; prolonged AV periods; DM; hypotension. Avoid abrupt withdrawal and long-term use. Patients with sick-sinus syndrome, preexisting AV block, bradycardia and those taking beta-blockers or digitalis are at risk of developing AV block, bradycardia, asystole or sinus arrest.
Take orally with food and water, as directed by your physician.
Keep in a cool, dry place away from sunlight and moisture.
This content is for educational purposes only. Please consult your doctor before use.
| Brand Name | Form | Price |
|---|---|---|
| ANO-metrogyl Cream 25gm | CREAM | ₹189.00 |
| Azmarda 50 mg Tablet 14s | TAB | ₹554.00 |
| Azovas 16mg Tablet 10s | TAB | ₹159.00 |
| Azovas 8mg Tablet 10s | TAB | ₹107.00 |
| Azovas T 8/40 Tablet 10s | TAB | ₹177.00 |
| Azovas T 80 Tablet 10s | TAB | ₹193.42 |
| Cefjoy 1500mg Inj. | INJECTION | ₹0.00 |
| Cefjoy 375mg Inj. | INJECTION | ₹0.00 |
| Cefjoy 750mg Inj. | INJECTION | ₹0.00 |
| Cilacar 10mg Tab | TAB | ₹58.07 |
| Cilacar 5mg Tab | TAB | ₹88.00 |
| Cilacar-T Tab | TAB | ₹77.00 |
| Daoryl-1mg Tab | TAB | ₹0.00 |
| Daoryl-2mg Tab | TAB | ₹0.00 |
| Daoryl-M1 Tab | TAB | ₹0.00 |
Written by: SastiMedic Medical Team
Reviewed by: Registered Pharmacist